








|
| Investment Strategy |
|
| The Chesapeake Core Growth Fund seeks capital appreciation
through investments in large capitalization growth equities. The cornerstone
of the Fund's intensive in-house fundamental analysis is constant
contact with the management, customers, competitors and suppliers
of both current and potential investments. |
 |
|
 |
| Monsanto Company |
4.0% |
| Google, Inc. Cl-A |
3.8% |
| MEMC Electronic Materials, Inc |
3.3% |
| CVS Corporation |
3.1% |
| McDermott International |
3.0% |
| Weatherford International, Ltd. |
3.0% |
| Baxter International, Inc. |
2.8% |
| Humana, Inc. |
2.6% |
| Oracle Corp. |
2.6% |
| Hewlett-Packard Co. |
2.6% |
Minor adjustments have been made to the percentages
of the ten largest holdings to compensate for shareholder activity.
To obtain a complete listing of the
Fund's portfolio of holdings as of the most recent quarter-end,
please click here.
All holdings information is provided for
informational purposes only and should not be deemed as a recommendation
to buy the securities mentioned. The holdings information represents
the largest holdings, by market value, in the Fund as of the most
recent quarter end. Each quarter, the Fund's Adviser uses this
same objective, non-performance based criteria to select the ten
largest holdings.
|
|
| Information Technology |
24.5% |
| Health Care |
21.7% |
| Financials |
12.5% |
| Consumer Discretionary |
11.2% |
| Industrials |
8.9% |
| Energy |
8.7% |
| Telecommunication Services |
5.1% |
| Materials |
4.0% |
| Consumer Staples |
3.1% |
| Utilities |
0.0% |
| Cash & Equivalents |
0.3% |
Minor adjustments have been made to the sector
weights to compensate for shareholder activity.
|
 |
| Number of Positions |
49 |
| Median Market Cap (in bil) |
$37.0 |
| P/E Ratio - 2008 Earnings Estimates |
17x |
*Source: Baseline Financial Services |
| |
Performance Summary
| |
1
Year |
3
Year |
5
Year |
10
Year |
| The
Chesapeake Core Growth Fund |
-6.99% |
4.12% |
8.07% |
7.25% |
Total Gross Expense Ratio as of 10/31/07 was 1.39%.
Net Expense Ratio as of 10/31/07 was 1.34%.
The Advisor has entered into a contractual
agreement with the Fund to waive its fees in an amount that limits Total
Annual Fund Operating Expenses to not more than 1.40% for the fiscal year
to end October 31, 2008. In addition, the Fund has entered into brokerage/service
arrangements with several brokers through commission recapture programs.
These portions are then used to offset overall Fund expenses. There can
be no assurance that these arrangements will continue in the future. For
more information, please see the prospectus.
|
Performance shown is for the period
ended June 30, 2008. The performance data quoted above represents
past performance, which is not a guarantee of future results. Investment
return and principal value of an investment will fluctuate so that
an investor’s shares, when redeemed, may be worth more or
less than their original cost. Current performance may be lower
or higher than the performance data quoted. To obtain more current
performance data regarding the Fund, including performance data
current to the Fund’s most recent month-end, please click
here.
The Chesapeake Core Growth
Fund’s inception date was September 29, 1997. During part
of the period cited the adviser assumed certain expenses and/or
waived a portion of its fee. Total return would have been lower
absent such assumptions or fee waivers. These fee waivers and/or
reimbursements are believed not to have had a significant effect
on the performance of the Fund.
Investment in the Fund is subject
to investment risks, including, without limitation, equity securities
risk, market risk, portfolio turnover risk, short-term investment
risk, investment adviser risk, overweighting in certain market sectors
risk and market segment risk. As an investor in the Fund, you are
subject to the risk that you may lose your money as a result of
the impact of the Fund’s investment risk on the Fund’s
net asset value per share. When you sell your investment in the
Fund, the value of your investment may be more or less than your
initial investment.
An investor should
consider the investment objectives, risks, and charges and expenses
of the Fund carefully before investing. The prospectus
contains this and other information about the Fund. A copy of the
prospectus is available by calling the Fund directly at (800) 430-3863
or the Fund’s adviser at (610) 558-2800. The prospectus should
be read carefully before investing.
|
|
Underwriter
and Distributor
Ultimus Fund Distributors, LLC
225 Pictoria Drive, Suite 450
Cincinnati, OH 45246
Phone (800) 430-3863 |
The Fund
is available for sale in the following states:
AK, AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, GU, HI, IA, ID,
IL, IN, KS, KY, LA,
MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH,
OK, OR, PA, PR, RI, SC, SD, TN, TX, UT, VA, VT, WA, WI, WV, WY |
|